RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 Using Pharmacogenetics and Advanced Neuroscience to Personalize Treatment of Psychiatric Illness
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 14
IS 44
SP 2
OP 4
DO 10.1177/155989771444001
UL http://mdc.sagepub.com/content/14/44/2.abstract
AB In any given year, 26.2% of individuals in the United States experience a diagnosable psychiatric illness. Approximately 6% of adults suffer from a seriously debilitating mental illness. Among adolescents aged 13 to 18 years, 46.3% experience symptoms of psychiatric illness, and 21.4% experience a severe disorder. This article discusses clinical tools for personalizing psycho-pharmacologic treatment, including psychopharmacogenetics, laboratory studies, review of systems, symptom evaluation, and observation.